ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,680 | +74.0% | 2,000 | +100.0% | 0.00% | 0.0% |
| Q2 2023 | $23,950 | +27.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $18,820 | +18.2% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $15,920 | -0.5% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $16,000 | +14.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $14,000 | -41.7% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $24,000 | +4.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $23,000 | -8.0% | 1,000 | -33.7% | 0.00% | 0.0% |
| Q3 2021 | $25,000 | -32.4% | 1,508 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $37,000 | -5.1% | 1,508 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $39,000 | -51.9% | 1,508 | 0.0% | 0.00% | -57.1% |
| Q4 2020 | $81,000 | +30.6% | 1,508 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $62,000 | +158.3% | 1,508 | +201.6% | 0.01% | +133.3% |
| Q2 2020 | $24,000 | +14.3% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $21,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |